More on SCTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $17.96 |
|
|||
| Open | $17.88 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $18.55 | ||||
| Day Low | $15.12 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 861,565 | ||||
- Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
- Scribe Therapeutics to Participate in Upcoming Investor Conferences
- H.C. Wainwright Starts Scribe Therapeutics Inc (SCTX) at Buy
- Scribe Therapeutics Inc (SCTX) PT Raised to $58 at Leerink
- Leerink Starts Scribe Therapeutics Inc (SCTX) at Outperform
- Wells Fargo Starts Scribe Therapeutics Inc (SCTX) at Overweight
- Guggenheim Starts Scribe Therapeutics Inc (SCTX) at Buy
- Goldman Sachs Starts Scribe Therapeutics Inc (SCTX) at Early-Stage Biotech
- Scribe Therapeutics raises $155.51M in IPO on Nasdaq
- Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
Entities mentioned with SCTX
- IPO | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Wells Fargo | View Related Stories »
- Goldman Sachs | View Related Stories »
- Guggenheim | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
